These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 560235)

  • 1. Studies on the rebound hypertension after clonidine withdrawal in conscious hypertensive cats, rats, and dogs [proceedings].
    Cavero I; Fénard S; Finch L; Lefevre F; Roach A
    Br J Pharmacol; 1977 Jun; 60(2):288P-289P. PubMed ID: 560235
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of central noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal.
    Augustine SJ; Buckley JP; Tachikawa S; Lokhandwala MF
    J Cardiovasc Pharmacol; 1982; 4(3):449-55. PubMed ID: 6177942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal experiments on the cardiovascular effects of lofexidine.
    Graf E; Doppelfeld IS; Prop G
    Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The withdrawal of centrally acting antihypertensives in dogs.
    Clough DP; Keddie J; Pettinger SJ
    Arzneimittelforschung; 1981; 31(11):1878-80. PubMed ID: 7198468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the rebound hypertension following withdrawal of clonidine treatment.
    Hong E; Moreno JA; Nava-Félix P
    Proc West Pharmacol Soc; 1985; 28():23-5. PubMed ID: 4070254
    [No Abstract]   [Full Text] [Related]  

  • 8. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the clonidine withdrawal syndrome in the normotensive rat.
    DiStefano P; Fox G; Johnson EM
    J Pharmacol Exp Ther; 1980 Aug; 214(2):263-8. PubMed ID: 6104723
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation syndrome after continuous infusion of clonidine in the spontaneously hypertensive rat.
    Thoolen MJ; Timmermans PB; van Zwieten PA
    Life Sci; 1981 May; 28(19):2103-9. PubMed ID: 7195968
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate.
    Cosnier D; Duchene-Marullaz P; Grimal J; Rispat G; Streichenberger G
    Arzneimittelforschung; 1975 Oct; 25(10):1557-61. PubMed ID: 1243037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of clonidine on three types of experimental hypertension and on plasma renin activity in dogs].
    Montastruc P; Montastruc JL; Moatti JP
    C R Seances Soc Biol Fil; 1978; 172(1):200-7. PubMed ID: 150895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on withdrawal related haemodynamic response in chronic propranolol treated conscious rats.
    Chakrabarti A; Sharma PL
    Indian J Physiol Pharmacol; 1993 Jul; 37(3):235-7. PubMed ID: 8276504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chronic oral administration of clonidine on the endogenous catecholamine metabolism in spontaneously hypertensive rats (author's transl)].
    Saito H; Koike Y; Yomaida I; Otani T; Togashi H
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):365-72. PubMed ID: 562829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the adrenergic reactivity of spontaneously hypertensive rats after abrupt withdrawal of chronic clonidine treatment.
    Staneva-Stoytcheva D; Raynova LL; Bogoslovova T; Ivanov D; Georgieva A
    Acta Physiol Pharmacol Bulg; 1985; 11(2):35-43. PubMed ID: 2996296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an animal model for the study of antihypertensive agents.
    Lublin CB; Conolly ME
    Proc West Pharmacol Soc; 1984; 27():333-6. PubMed ID: 6541789
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of continuous infusion and sudden withdrawal of azepexole (B-HT 933) on blood pressure and heart rate in the spontaneously hypertensive and normotensive rat. Suppression of the withdrawal responses by morphine.
    Thoolen MJ; Timmermans PP; van Zwieten PA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):786-91. PubMed ID: 7197720
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between activity and structure in derivatives of clonidine.
    Hoefke W; Kobinger W; Walland A
    Arzneimittelforschung; 1975 May; 25(5):786-93. PubMed ID: 1242325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications following withdrawal of antihypertensive drugs. I. Hypertensive rebound phenomenon].
    Laham E
    Sem Hop; 1979 Nov 18-25; 55(39-40):1811-6. PubMed ID: 232778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.